Journal Article

Chemopreventive effect of 24<i>R</i>,25-dihydroxyvitamin D<sub>3</sub> in <i>N</i>,<i>N</i>′-dimethylhydrazine-induced rat colon carcinogenesis

Tetsuhide Taniyama, Hideki Wanibuchi, Elsayed I. Salim, Yoshihisa Yano, Shuzo Otani, Yoshiki Nishizawa, Hirotoshi Morii and Shoji Fukushima

in Carcinogenesis

Volume 21, issue 2, pages 173-178
Published in print February 2000 | ISSN: 0143-3334
Published online February 2000 | e-ISSN: 1460-2180 | DOI:
Chemopreventive effect of 24R,25-dihydroxyvitamin D3 in N,N′-dimethylhydrazine-induced rat colon carcinogenesis

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics


Show Summary Details


In this study we investigated the effects of 24R,25-dihydroxyvitamin D3 [24R,25(OH)2D3] on N,N′-dimethylhydrazine (DMH)-induced rat colon carcinogenesis. For experiments 1 and 2, 50 F344 male, 6-week-old rats were divided into five groups in each experiment. Animals were given s.c. injections of DMH once a week for 4 weeks. Those in groups 1–5 were given 24R,25(OH)2D3 in the diet (10, 5, 2.5, 1.25 or 0 p.p.m., respectively) during the post-initiation stage in experiment 1 and during the initiation stage in experiment 2. At termination, the numbers of aberrant crypt foci (ACF) in the rat colonic mucosa were decreased dose-dependently in rats treated with 24R,25(OH)2D3 during the post-initiation stage, but not in the initiation stage. For experiment 3, 15 male, 9-week-old rats were divided into three groups and given 24R,25(OH)2D3 in the diet (10, 5 or 0 p.p.m.). Animals were injected with 5-bromo-2′-deoxyuridine (BrdU) i.p. 1 h before death to examine DNA synthesis in the colon mucosa. BrdU labeling indices were decreased dose-dependently in colonic crypts of rats treated with 24R,25(OH)2D3. In experiment 4, using the multicarcinogenic protcol we could analyze our data with respect to not only one separate organ, but at the organism level. Sixty-eight male, 6-week-old rats were treated with DMH, N-methylnitrosourea, 2,2′-dihydroxy-di-n-propylnitrosamine, diethylnitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine in weeks 1–4 and were then given 24R,25(OH)2D3 in the diet (5, 1 or 0 p.p.m.) throughout weeks 5–30. Examination of the development of tumors and preneoplastic lesions in various organs revealed that 24R,25(OH)2D3 inhibited colonic tumor development significantly but exerted no effects on tumor induction in other organs. In conclusion, these results strongly indicate that 24R,25(OH)2D3 inhibits colon carcinogenesis specifically, without any enhancement of carcinogenesis in other organs, when administered in the post-initiation phase.

Keywords: ACF, aberrant crypt foci; BBN, N-butyl-N-(4-hydroxybutyl)nitrosamine; BrdU, 5-bromo-2′-deoxyuridine; COX, cyclooxygenase; DEN, diethylnitrosamine; DHPN, 2,2′-dihydroxy-di-n-propylnitrosamine; DMBDD treatment, combined carcinogen treatment; 1,25(OH)2D3, 1,25-dihydroxyvitamin D3; 24R,25(OH)2D3, 24R,25-dihydroxyvitamin D3; DMH, N,N′-dimethylhydrazine; GST-P, glutathione S-transferase placental form; MNU, N-methylnitrosourea; ODC, ornithine decarboxylase; SAT, spermidine/spermine N1-acetyltransferase.

Journal Article.  4707 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.